Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
don't worry, they'll be up tomorrow
spreading lies isn't being realistic.
don't worry, everyone will get get a picture posted as proof. I'm not on here to spread falsehoods. I rarely post, but when I do I try to keep it to facts... not baseless garbage and tasteless jokes.
Exactly, I work for Shell and it is ending its LEASE at the downtown Houston location, One Shell Plaza.
Indeed.
90% of mgmt compensation is equity (ESOP - employees stock option plan), so they definitely care about pps.
Almost all other U.S trading cannabis companies including GWP# are down,
but unlike many of them, OWCP did announce how they are trying to respond to the negative performance by entering into the Canadian stock exchange as we saw in the recent 8-k:
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12117417
OWCP is working according to its reported business and operating plan. They're still in target for the psoriasis cream to be market ready by end of Q2. They report on any substantial and/or newsworthy development, but they will not invent news and pump PRs to mislead investors.
Shareholders should be patient and read all DD and news from 01/2017 to date and see how much OWCP has actually achieved within 6 months. This is the biopharmaceutical sector and milestones aren't achieved overnight.
OWCP believes that what they have is unique and is a breakthrough. They said we can expect updates within the next couple weeks, so I plan on waiting until then before looking for a torch and pitchfork.
GLTA $OWCP
I'll be there and have a scheduled meeting with Mr. Hanks. Everyone can let me know what they would like to address and I'll raise them... last couple days to collect questions.
Same here... can only hope based on what I was told when I spoke with OWCP. Phone convo with Jeff and email reply from Alon. Both say expect updates within the next couple weeks. I don't doubt we get something, only question is will the information be substantial enough to get us out of this rut.
This is what I've been told as well
assuming you mean Monday...
I wouldn't say I'm unhappy. One can only expect so much when trying to get further details without it becoming insider information.
Expectation that a string of updates will be provided within the next couple weeks is promising. However, I think it's safe to say this stock is will be toast if we don't get something really soon... even a couple weeks is pushing it.
I suggest those who are interested to reach out to Jeff about updates, concerns, etc.
Jeff S
Business Development
(561) 703-3309
Boca Raton, FL
USA
Expect string of updates within the a couple weeks... sorry can't share further details on board. Everyone should do their own DD anyways and not take my word for it.
My concerns and frustrations aren't completely alleviated, but hopefully we'll see the mentioned communications start within the next 2 weeks.
yep, responded in 7 minutes.
Just got a reply to my email from Jeff including this contact info asking me to call him. Calling him today, what does everyone want to know?
thanks...
but a Gmail account?
sent an email to IR and received the same generic reply pretty much...
sent a another message to IR, let's see if I get a reply... didn't last time.
Seriously, 100 shares at .0026?
this has really become pathetic...
I'm curious to see what Mr. Hanks is going to tell me to my face when I ask him what is going on.
Pretty much over this company.
this has really become pathetic...
Guessing you sold your .011 positions for a loss then?
probably won't see much of a pop in $/bbl in the immediate future unfortunately...
http://www.cnbc.com/2017/06/07/oil-rises-off-1-month-lows-struck-after-surprise-stock-build.html
I hear you. I'm holding and waiting for CE removal... the PGPM beast will wake back up.
we get great news and pps dips... sucks
damn this is brutal...
Lol, you're seriously ridiculous... guess you should've waited a little longer to get back in, huh? Never got that pump back to 0.015
Proof?
or just another baseless statement?
Mods, sticky this please
Since you can't seem to look at his, Jeff Smurlick who consults for OWCP (On-Topic), LinkedIn profile for yourself, here's an excerpt:
Wireless Business Solutions
Sprint
March 2009 – May 2015 (6 years 3 months)
Fort Lauderdale, FL
Jeff is a four [4] time Presidents Circle Winner at Sprint including the latest top executive President's Honors recipient in 2013 and Q2 Solutions Masters Winner. Sprint, where your enterprise requires high performance on a daily basis and Sprint, its mobility solution partners coupled with the CDMA / LTE digital network, is the right technology provider to achieve that. Sprint's business M2M and software solutions can arm your organization with innovative mobility tools that run on the most powerful network, creating greater efficiencies with increasing investment returns.
Global Enterprise Manager
AT&T
March 2006 – June 2008 (2 years 4 months)
Boca Raton, FL
Managed multi-million dollar Global Accounts for companies of over 10,000 employees. Managed the account teams including (solution engineers, project managers, care managers and the implementation team) to service various multi-national named accounts based in South Florida by providing a combination of complex overall solutions.
Solutions Manager
Sprint
July 1998 – March 2006 (7 years 9 months)
Sunrise, FL
Contributed millions in gross sales for Sprint PCS with new Corporate Logos and renewed existing business contracts. Ranked #1 in overall performance for entire Country / 2 x Pinnacle Winner [highest Performance Award given] / Promoted to Major and later National Account Manager positions / Promoted to Solutions Management.
https://www.linkedin.com/in/jeffsmurlick/
I don't think we need to worry about Jeff Smurlick's credibility... he's held high ranking positions with more than reputable companies (e.g. Sprint, AT&T, and Comcast).
Lol... ergo
that's exactly one of the questions I asked in my initial email to them and I'll ask again in person.
got it, what else does everyone want to know?
yep, on my list. anyone else?
I have been in communication with Mr. Hanks and Ms. Zimmons and I will be meeting with him during the summit. If you have questions you would like answered, let me know and I will add them to my list.
yw... trying to post something other than just noise and opinion which is what this board mostly consists of these days.
not too shabby for the cream's rollout ;)
Germany has quite a market for psoriasis, approximately 2.5% of it’s population, which is ~2 Million people, are treated because of psoriasis per this study - https://www.ncbi.nlm.nih.gov/pubmed/20544588
From a global view, psoriasis is increasing in incidence and prevalence -
http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf
From Page 10: Tracking trends in incidence and prevalence of psoriasis is difficult, due to the different methodologies of research on this issue. However, an apparent upward trend is observed in several countries. The prevalence of psoriasis in China in 1984 was 0.17%, while 25 years later, another study found it to be 0.59% (37,43). The prevalence in Spain in 1998 was 1.43%, while 15 years later it was reported as 2.31% (86,87). Data on the prevalence in the United States from the National Health and Nutrition Examination Survey indicated an increase in prevalence from 1.62% to 3.10% from 2004 to 2010 (46,69). However, different methodologies of conducting these studies, especially in view of the various case definitions of psoriasis, do not allow for a clear assessment of the increasing trend. The most instructive study of trends in prevalence is a 30-year follow-up of a population-based cohort in Tromsø, Norway (3). Analyses of trends in prevalence during 1979–2008 indicate that self-reported lifetime prevalence of psoriasis (in the same cohort) has increased from 4.8% to 11.4%.
Germany is serious about its fight against psoriasis.
From Page 28: Box 1. Model for improving psoriasis care on a national basis: the German experience One example of a large-scale programme to improve health care for psoriasis is the German experience. The approach for improving psoriasis care in Germany started in 2005 with a systematic analysis of the quality, outcomes and potential barriers of health care for psoriasis (172). A series of national health-care studies revealed severe deficits in both the access to modern drugs and the lack of a national guidance, and a large number of patients with high disease severity. Following the development of a psoriasis guideline as a matrix of care in 2006, this was systematically implemented in regional psoriasis networks and evaluated in national trials (172). After making only minor initial improvements, national goals on psoriasis care for 2010–2015 were released in a broad national consensus by dermatology societies, patient groups and decision-makers. These goals are: (i) better QoL for the patients; (ii) earlier detection and better treatment of psoriatic arthritis; (iii) other comorbidity; and (iv) better health care for children with psoriasis. About 28 regional psoriasis networks were established throughout the country to coordinate high-level health care for psoriasis patients by dermatological experts. In doing so, the latest follow-up data from 2014, which were randomly collected countrywide, revealed significant improvements both on the clinical level of severity and QoL as well as for indirect costs and days of work lost (172). This shows that once health-care providers and patients have reached a consensus, systematic programmes based on standardization, goal orientation and communication at the patient level as well as on the health system level can be successful. This national programme has served as a model for the European Psoriasis White Paper (167) and could be considered by other countries, including for the management of other chronic (skin) diseases.
last thing I could find... mediq is a partner of LifeSci of which David Furst is also the President and CEO -
http://www.lifesci.biz/Partners.asp
Did some more digging and found some information on David Furst, Managing Director for mediq Innovation Experts (Israel).
https://www.linkedin.com/in/furstdavid/
Also found this interesting video interviewing David regarding his Parkinson's. Not only is he working hard to bring helpful medicine to market, but he's also a patient himself.
https://37degreescelsius.net/conference-program/
Looks like Jan Wende of mediq Innovations Experts will be at this conference and participating in panel at 10:30-11:15 discussing "the clinical trials aspects of market entry; comparing modus operandi in different countries; Impact of new EU regulations; The role that clinical studies plays in sustaining and building industry; Impact of digital technology, AI and personalised medicine."
Looks like he'll have some good company on the panel and at the conference as a whole.